California State University, Northridge WordmarkOviatt Library WordmarkOviatt Library Catalog Wordmark
Title Theranostics, gallium-68, and other radionuclides : a pathway to personalized diagnosis and treatment / Richard P. Baum, Frank Rösch, editors.
Published Heidelberg ; New York : Springer Verlag, c2013.
Book Cover

 Floor4  RC261 .R35 no.194 2013    IN LIBRARY
Description xviii, 576 p. : ill. (some col.) ; 24 cm.
Series Recent results in cancer research, 0080-0015 ; 194
Recent results in cancer research ; 194. 0080-0015
Bibliography Includes bibliographical references.
Contents Part 1. Generators -- ⁶⁸Ge /⁶⁸Ga Generators: Past, Present, and Future -- Overview and Perspectives on Automation Strategies in ⁶⁸Ga Radiopharmaceutical -- Post-Processing via Cation Exchange Cartridges: Versatile Options -- ⁶⁸Ga Generator Integrated System: Elution-Purification-Concentration Integration -- Purification and Labeling Strategies for ⁶⁸Ga from ⁶⁸Ge /⁶⁸Ga Generator Eluate -- 67Ga and ⁶⁸Ga Purification Studies: Preliminary Results -- Part 2. Radiochemistry and Radiopharmacy -- The Diversity of ⁶⁸Ga-Based Imaging Agents -- Nanoparticles and Phage Display Selected Peptides for Imaging and Therapy of Cancer -- Click-Cyclized ⁶⁸Ga-Labeled Peptides for Molecular Imaging and Therapy: Synthesis and Preliminary In Vitro and In Vivo Evaluation in a Melanoma Model System -- Early Experience with ⁶⁸Ga-DOTATATE Preparation -- ⁶⁸Ga-Radiopharmaceuticals for PET Imaging of Infection and Inflammation -- ⁶⁸Ga-Labeled Bombesin Analogs for Receptor-Mediated -- A Novel ⁶⁸Ga-Labeled Pteroic Acid-Based PET Tracer for Tumor Imaging via the Folate Receptor -- Measurement of Protein Synthesis: In Vitro Comparison of ⁶⁸Ga-DOTA-Puromycin, [³H]Tyrosine, and 2-Fluoro-[³H]tyrosine -- Hypoxia Imaging Agents Labeled with Positron Emitters -- ¹⁷⁷Lu /⁹⁰YIntermediate-Affinity Monoclonal Antibodies Targeting EGFR and HER2 /c-neu: Preparation and Preclinical Evaluation -- Part 3. Molecular Imaging Using Ga-68 labeled Tracers -- Divergent Role of ⁶⁸Ga-Labeled Somatostatin Analogs in the Workup of Patients with NETs: AIIMS Experience -- Differential Uptake of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE in PET /CT of Gastroenteropancreatic Neuroendocrine Tumors -- High Uptake of ⁶⁸Ga-DOTATOC in Spleen as Compared to Splenosis: Measurement by PET /CT -- Rare Metastases Detected by ⁶⁸Ga-Somatostatin Receptor PET /CT in Patients with Neuroendocrine Tumors -- Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature -- PET Lung Ventilation /Perfusion Imaging Using ⁶⁸Ga Aerosol (Galligas) and ⁶⁸Ga-Labeled Macroaggregated Albumin -- Combined PET /MR Imaging Using ⁶⁸Ga-DOTATOC for Radiotherapy Treatment Planning in Meningioma Patients -- Part 4. Targeted Radiotherapy (Peptide Receptor Radionuclide Therapy) and Dosimetry -- A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign -- Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors in Germany: First Results of a Multi-institutional Cancer Registry -- Polish Experience in Peptide Receptor Radionuclide Therapy -- PRRT as Neoadjuvant Treatment in NET -- Intraoperative Somatostatin Receptor Detection After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu- and ⁹⁰Y-DOTATOC (Tandem PRRNT) in a Patient with a Metastatic Neuroendocrine -- Personalized Image-Based Radiation Dosimetry for Routine Clinical Use in Peptide Receptor Radionuclide Therapy: Pretherapy Experience -- The Bad Berka Dose Protocol: Comparative Results of Dosimetry in Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE, ¹⁷⁷Lu-DOTANOC, and ¹⁷⁷Lu-DOTATOC . -- 4D SPECT /CT Acquisition for 3D Dose Calculation and Dose Planning in ¹⁷⁷Lu-Peptide Receptor Radionuclide Therapy: Applications for Clinical Routine -- Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu Labeled Somatostatin Analogs DOTATATE and DOTATOC: Contrasting Renal Dosimetry in the Same Patient -- Is There a Correlation Between Peptide Receptor Radionuclide Therapy-Associated Hematological Toxicity and Spleen Dose? -- Old and New Peptide Receptor Targets in Cancer: Future Directions.
Subject Radioisotopes -- Therapeutic use.
Radioisotopes in medical diagnosis.
Molecular diagnosis -- Congresses.
Related Names Baum, Richard P., 1954-
Rösch, Frank.
ISBN 9783642279935 (alk. paper)
3642279937 (alk. paper)
9783642279942 (eBook)
3642279945 (eBook)
OCLC number 772113827